LGM
HRMY icon

Logos Global Management’s Harmony Biosciences HRMY Stock Holding History

Logos Global Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100,000
Closed -$3.3M – 62
2021
Q1 		$3.3M Hold
100,000
– – 0.32% 40
2020
Q4 		$3.62M Sell
100,000
-175,000
-64% -$7.06M 0.31% 43
2020
Q3 		$9.32M Buy
+275,000
New +$10M 1.19% 21

Other funds holding HRMY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Logos Global Management's HRMY Position: Q2 2021 in Review

Logos Global Management sold out of Harmony Biosciences (HRMY) in Q2 2021, closing a stake of 100,000 shares — an estimated $3.3M sold.

Logos Global Management first reported a position in HRMY in Q3 2020 and held it in 3 quarters. The position peaked at $9.32M in Q3 2020. 84 funds tracked by Wall St. Rank hold HRMY as of Q2 2021.

  • Logos Global Management reported no remaining Harmony Biosciences position as of Q2 2021 after selling out during the quarter.
  • Logos Global Management sold 100,000 Harmony Biosciences shares in Q2 2021, an estimated $3.3M.
  • Logos Global Management first reported a position in Harmony Biosciences in Q3 2020 and held it in 3 quarters.
  • Logos Global Management's Harmony Biosciences position peaked at $9.32M in Q3 2020.
  • 84 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2021.

Based on Logos Global Management's 13F filing for Q2 2021, filed 16 Aug 2021.